Clinical Trials in Padova, PD
25 recruiting
Showing 1–20 of 25 trials
Recruiting
Phase 1Phase 2
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
Progressive Metastatic Castrate Resistant Prostate Cancer
Novartis Pharmaceuticals188 enrolled30 locationsNCT07206056
Recruiting
Phase 2
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone Sensitive Prostate Cancer
Novartis Pharmaceuticals150 enrolled65 locationsNCT06991556
Recruiting
Phase 2
Zanubritnib and Anti-MAG Neuropathy
Anti-MAG IgM-associated Demyelinating Polyneuropathy
Azienda Ospedaliera di Padova50 enrolled1 locationNCT07392229
Recruiting
Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patients
EGFR-mutated NSCLC
Gruppo Oncologico Italiano di Ricerca Clinica100 enrolled25 locationsNCT07363252
Recruiting
Phase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
Aortic Stenosis
Novartis Pharmaceuticals502 enrolled139 locationsNCT05646381
Recruiting
Phase 4
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Sickle Cell Disease
Novartis Pharmaceuticals130 enrolled30 locationsNCT04657822
Recruiting
Phase 2
A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Calluna Pharma AS150 enrolled54 locationsNCT06736990
Recruiting
Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC
HER2NSCLC (Advanced Non-small Cell Lung Cancer)
Gruppo Oncologico Italiano di Ricerca Clinica50 enrolled22 locationsNCT07356544
Recruiting
stereOtactic Body RadIothErapy for exTracranial oligomeTastAtic Breast Cancer: Multi Institutional Retrospective Database
Breast CancerOligometastasis
Istituto Clinico Humanitas300 enrolled28 locationsNCT07397585
Recruiting
Phase 1Phase 2
5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano27 enrolled3 locationsNCT04689347
Recruiting
European Unified Registries for Heart Care Evaluation and Randomised Trials Italy
ACS (Acute Coronary Syndrome)
Heart Care Foundation5,000 enrolled57 locationsNCT07283809
Recruiting
Observational Study on Endometrial Stromal Tumors
Endometrial Stromal Tumors
Italian Sarcoma Group100 enrolled13 locationsNCT02829437
Recruiting
Phase 3
FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
Colorectal, Cancer
Gruppo Oncologico del Nord-Ovest238 enrolled24 locationsNCT06733038
Recruiting
Sarcopenia in Gestational Diabetes
SarcopeniaCognitive FunctionPregnancy Complications+2 more
Istituto di Neuroscienze Consiglio Nazionale delle Ricerche200 enrolled3 locationsNCT06876090
Recruiting
ALFAOMEGA Master Observational Trial
Colorectal, Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology3,000 enrolled19 locationsNCT04120935
Recruiting
Not Applicable
Assessment of Eye Movements in Stroke Patients and Closed-loop Intervention
Stroke
IRCCS San Camillo, Venezia, Italy30 enrolled2 locationsNCT06965673
Recruiting
SerpinB3 Expression, PAR2 and SCCA-PD Polymorphism in Acute Respiratory Distress Syndrome
Respiratory FailureRespiratory Distress Syndrome (RDS)
University of Padova40 enrolled1 locationNCT06774534
Recruiting
Measure of Outcomes in Patients With Advanced Ovarian Cancer According to Homologous Recombination Status and Matched Therapies in a Real-world Scenario
Ovarian Cancer
Consorzio Oncotech300 enrolled21 locationsNCT06836219
Recruiting
Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC)
IRCCS Azienda Ospedaliero-Universitaria di Bologna1,000 enrolled24 locationsNCT06806579
Recruiting
Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.
Aneurysmal subarachnoid haemorrhageDelayed Ischemic Neurological Deficit
Fondazione IRCCS San Gerardo dei Tintori1,400 enrolled33 locationsNCT06804421